Funder
The Coordination of Scientific Research Projects, University of Selcuk, Turkey
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference39 articles.
1. Kumar A, Gautam B, Dubey C, Tripathi PK. A review: role of doxorubicin in treatment of cancer. Int J Pharm Sci Rev Res. 2014;5(10):4117–288.
2. Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, Moreira PI. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem. 2009;16:3267–85.
3. Kaye S, Merry S. Tumour cell resistance to anthracyclines—a review. Cancer Chemother Pharmacol. 1985;14:96–103.
4. Sadzuka Y, Egawa Y, Sawanishi H, Miyamoto K, Sonobe T. Effects of xanthine derivatives on the influx and efflux of doxorubicin in P388 and DOX-resistant P388 leukemia cells. Toxicol Lett. 2002;135:137–44.
5. Gustafson DL, Merz AL, Long ME. Pharmacokinetics of combined doxorubicin and paclitaxel in mice. Cancer Lett. 2005;220:161–9.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献